Try our beta test site
2 studies found for:    lymphoma OR CLL | cd70
Show Display Options
Rank Status Study
1 Completed A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell;   Lymphoma, Non-Hodgkin
Intervention: Drug: SGN-75
2 Recruiting Safety Study of SGN-CD70A in Cancer Patients
Conditions: Renal Cell Carcinoma;   Mantle-Cell Lymphoma;   Diffuse, Large B-Cell, Lymphoma;   Follicular Lymphoma, Grade 3
Intervention: Drug: SGN-CD70A

Study has passed its completion date and status has not been verified in more than two years.